课题基金 / 基金详情

Investigation on the role of Rho A in the progression of renal injury

Investigation on the role of Rho A in the progression of renal injury
Rho A在肾损伤进展中的作用研究
批准号:
12671048
负责人:
HAYASHI Koichi
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

HAYASHI Koichi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A growing number of studies have demonstrated that Rho kinase participates importantly in the vasomotor regulation, as well as in the pathogenesis of various diseases, including vascular hypertrophy and atherosclerosis. The aims of the current project are to clarify the role of Rho kinase in mediating the control of renal vascular tone under basal and angiotensin II-stimulated conditions in renal arterioles of Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR), using the isolated perfused hydronephrotic rat kidney. When administered under basal vascular tone, Y-27632 caused dose-dependent dilation of afferent arterioles in WKY and SHR. Y-27632 also reversed angiotensin II-induced afferent arteriolar vasoconstriction, with 83% reversal at 10^<-5> mol/l in WKY. In contrast, the ability of Y-27632 to inhibit the KCl-induced afferent arteriolar constriction was diminished; only 38% reversal was observed at 1-^<-5> mol/l. In SHR, Y-27632 inhibited the angiotensin II-induced a … More fferent arteriolar constriction to the degree similar to that observed in WKY. The Y-27632-induced vasodilation of KCl-constricted afferent arterioles, however, was enhanced in SHR, compared with that in WKY. We further examined the effect of fasudil, a Rho-kinase inhibitor, on the progression of renal injury in salt-loaded subtotally nephrectomized SHR (SHR-Nx). In SHR-Nx treated with fasudil (3 mg/kg/day, ip), systolic blood pressure was progressively elevated (from 151±4 to 208±8 mmHg at 8 weeks, n=8), which was not different from that in SHR-Nx without fasudil (from 149±3 to 217±14mmHg, n=8). Urinary protein excretion was markedly increased in SHR-Nx (from 21±1 to 124±16mg/day at 8 weeks), but this increase was significantly suppressed by fasudil (to 79±12mg/day at 8 weeks). Renal histological examination revealed that fasudil improved glomerular (77±5 vs. 60±5, p<0.05) and tubulointerstitial injury scores )1.7±0.3 vs. 0.8±0.2, p<0.05), with parallel amelioration of proliferating cell nuclear antigen-positive cell infiltration (glomerulus, 30±4 vs. 18±3, p<0.05; tubulointerstitium, 12±1 vs. 5±2, p<0.05). In conclusions, the present study demonstrates important roles of Rho kinase pathways in mediating the renal arteriolar tone. The contribution of Rho kinase- associated calcium sensitivity to the renal arteriolar constriction, however, differs, depending on the underlying vasoconstrictor stimuli used. Furthermore, the role of Rho/ROCK in renal vasoconstriction was altered in SHR. Finally, Rho-kinase pathway is involved in the pathogenesis of renal injury, and we suggest that the inhibition of Rho-kinase may constitute a therapeutic strategy for the treatment of renal injury. Less
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Nakamura A.: "Role of Rho/ROCK in afferent arteriolar tone"Keio Igaku. 78. 21-30 (2001)
Nakamura A.:“Rho/ROCK 在传入小动脉音调中的作用”Keio Igaku。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Honda M: "Divergent renal vasodilator action of L-and T-type calcium antagonists in vivo"Journal of Hypertension. 19. 2031-2037 (2001)
Honda M:“L-和T-型钙拮抗剂在体内的不同肾血管舒张作用”高血压杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Honda M, et al.: "Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo"Journal of Hypertension. 19. 2031-2037 (2001)
Honda M 等人:“体内 L 型和 T 型钙拮抗剂的不同肾血管舒张作用”高血压杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nagahama T: "Role of protein kinase C in angiotensin II-induced constriction of renal microvasculature"Kidney International. 57. 215-223 (2000)
Nagahama T:“蛋白激酶 C 在血管紧张素 II 诱导的肾微血管收缩中的作用”肾脏国际。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Development of inverse photoelectron holography targeting light elements and its application to advanced materials
    • 批准号:
      16H03849
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.82万
    • 财政年份:
      2016
    • 负责人:
      HAYASHI Koichi
    • 依托单位:
    Therapeutic strategy for chronic kidney disease and hypertension based on time/metabolism regulation.
    • 批准号:
      22590915
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2010
    • 负责人:
      HAYASHI Koichi
    • 依托单位:
    Study on combustion Mechanism of Bio Fuel Including Detonation
    • 批准号:
      21360420
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2009
    • 负责人:
      HAYASHI Koichi
    • 依托单位:
    Anti-aging therapy against chronic kidney disease
    • 批准号:
      19590963
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      HAYASHI Koichi
    • 依托单位:
    海外基金